* Helius Medical Technologies Inc HSDT.OQ reported a
quarterly
adjusted loss of $1.47 per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $-8.50. The mean expectation of
three analysts for the quarter was for a loss of $3.77 per
share. Wall Street expected results to range from $-4.05
to $-3.38 per share.
* Revenue fell 52.5% to $134.00 thousand from a year ago;
analysts
expected $246.33 thousand.
* Helius Medical Technologies Inc's reported EPS for the
quarter
was a loss of $1.47.
* The company reported a quarterly loss of $1.05 million.
* Helius Medical Technologies Inc shares had fallen by 30.3%
this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 3.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Helius Medical
Technologies Inc is $20.00
This summary was machine generated from LSEG data March 28 at
09:02 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -3.77 -1.47 Beat
Sep. 30 2023 -6.00 -5.49 Beat
Jun. 30 2023 -5.83 -3.00 Beat
Mar. 31 2023 -5.50 -4.50 Beat